Buske C - Search Results

1

Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.

Braess J, Spiekermann K, Staib P, Grüneisen A, Wörmann B, Ludwig WD, Serve H, Reichle A, Peceny R, Oruzio D, Schmid C, Schiel X, Hentrich M, Sauerland C, Unterhalt M, Fiegl M, Kern W, Buske C, Bohlander S, Heinecke A, Baurmann H, Beelen DW, Berdel WE, Büchner T, Hiddemann W. Braess J, et al. Among authors: buske c. Blood. 2009 Apr 23;113(17):3903-10. doi: 10.1182/blood-2008-07-162842. Epub 2009 Jan 8. Blood. 2009. PMID: 19131552 Free article. Clinical Trial.

2

Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblasts.

Buske C, Hiddemann W, Wörmann B. Buske C, et al. Cell Biol Int. 1994 Nov;18(11):1049-58. doi: 10.1006/cbir.1994.1028. Cell Biol Int. 1994. PMID: 7894389

3

Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells.

Wulf GG, Jahns-Streubel G, Strutz F, Basenau D, Hüfner M, Buske C, Wörmann B, Hiddemann W. Wulf GG, et al. Among authors: buske c. Ann Hematol. 1996 Sep;73(3):139-41. doi: 10.1007/s002770050215. Ann Hematol. 1996. PMID: 8841102

4

TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Wulf G, Schäfer C, Hiddemann W, Wörmann B. Buske C, et al. Leukemia. 1997 Mar;11(3):386-92. doi: 10.1038/sj.leu.2400586. Leukemia. 1997. PMID: 9067578

5

Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.

Buske C, Gogowski G, Schreiber K, Rave-Fränk M, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1997 Apr;25(4):329-37. Exp Hematol. 1997. PMID: 9131008

6

Treatment of follicular follicle centre lymphomas: current status and future perspectives.

Hiddemann W, Unterhalt M, Buske C, Sack H. Hiddemann W, et al. Among authors: buske c. J Intern Med Suppl. 1997;740:55-62. J Intern Med Suppl. 1997. PMID: 9350184 Review.

7

[Systemic therapy of low malignancy non-Hodgkin lymphomas].

Wörmann B, Buske C, Hiddemann W. Wörmann B, et al. Among authors: buske c. Praxis (Bern 1994). 1998 Jun 3;87(23):806-11. Praxis (Bern 1994). 1998. PMID: 9654987 Review. German.

8

TGF-beta and its receptor complex in leukemic B-cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Griesinger F, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1998 Nov;26(12):1155-61. Exp Hematol. 1998. PMID: 9808055

9

Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission.

Feuring-Buske M, Haase D, Buske C, Hiddemann W, Wörmann B. Feuring-Buske M, et al. Among authors: buske c. Leukemia. 1999 Mar;13(3):386-92. doi: 10.1038/sj.leu.2401300. Leukemia. 1999. PMID: 10086729

10

[Monoclonal antibodies in therapy of malignant lymphomas].

Buske C, Engert A, Schnell R, Diehl V, Hiddemann W. Buske C, et al. Internist (Berl). 1998 Dec;39(12):1205-14. doi: 10.1007/s001080050292. Internist (Berl). 1998. PMID: 10198827 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters